Transverse Rectus Abdominis Myocutaneous Flap Research Articles

Quality of life in patients undergoing transverse rectus abdominis myocutaneous flap breast reconstruction

A Revista Brasileira de Cirurgia Plástica é o órgão oficial de divulgação da Sociedade Brasileira de Cirurgia Plástica (SBCP), tem como objetivo registrar a produção científica em Cirurgia Plástica, fomentar o estudo, aperfeiçoamento e atualização dos profissionais da especialidade.

Breast Reconstruction Using Implant: Long Term Follow-up Complications & Patient's Satisfaction

As incidence rate of breast cancer has recently increased, more attention has been paid to breast reconstruction. The goal of breast reconstruction is to reconstruct breast in proper size, location and shape, symmetry on both sides, and nipple-areolar complex [1]. In general, reconstruction method includes the method that uses autologous tissue such as transverse rectus abdominis myocutaneous flap or latssimus dorsi flap and the method that uses implant or prosthesis. In case that amount of autologous tissue is insufficient, a patient has experience of receiving surgery on abdomen, or a patient refuses to undergo surgery using autologous tissue, implant is used to perform breast reconstruction. Breast reconstruction using implant has many strong points such as short time for surgery, relatively low level of technique, low expenses, a few scars that are left behind after surgery, no morJong Won Rhie*, Tae Seob Kim*, Han Young Yoon, Jeong Su Shim, Ki Young Ahn, Sung Hwan Park

The ability of intra-operative perfusion mapping with laser-assisted indocyanine green angiography to predict mastectomy flap necrosis in breast reconstruction: A prospective trial

Mastectomy skin flap ischaemia leading to necrosis is a common occurrence. Laser-assisted indocyanine green (ICG) angiography can assist to locate these poorly perfused areas intra-operatively. Our study aims to identify specific perfusion values produced by ICG angiography that accurately predict mastectomy flap necrosis. A total of 42 patients undergoing autologous or implant-based breast reconstruction had mastectomy flaps imaged using laser-assisted ICG angiography at the completion of reconstruction. Intra-operative perfusion values were correlated with postoperative skin flap outcomes. Risk factors for abnormal perfusion were recorded and analysed. A total of 62 breast reconstructions were imaged, including 48 tissue expander reconstructions, six transverse rectus abdominis myocutaneous (TRAM) flaps, six deep inferior epigastric perforator (DIEP) flaps and two direct-to-implant reconstructions. Eight cases (13%) of full-thickness skin necrosis were identified postoperatively. A SPY Elite(®) value of ≤ 7 accurately predicted the development of flap necrosis at 88% sensitivity and 83% specificity. False-positive cases (those with perfusion values ≤ 7 which did not develop necrosis) were more likely to have a smoking history and/or to have had an epinephrine-containing tumescent solution used during mastectomy. Excluding patients with smoking or epinephrine use, a SPY value of ≤ 7 predicted flap necrosis with a sensitivity of 83% and specificity of 97%. Thus, these data suggest that laser-assisted ICG angiography predicts postoperative outcomes with high accuracy. In our series, a SPY value of ≤ 7 correlated well with mastectomy flap necrosis. Furthermore, smoking and intra-operative injections containing epinephrine should be considered when evaluating low perfusion values as they can lead to false-positive test results.

Comparison of TRAM versus DIEP Flap in Total Vaginal Reconstruction after Pelvic Exenteration

The purpose of this study was to compare the transverse rectus abdominis myocutaneous (TRAM) pedicled flap with a muscle and fascia-sparing flap based on the deep inferior epigastric perforator (DIEP) in total vaginal reconstruction. The authors studied the advantages and disadvantages of both flaps. From January of 1986 to July of 2010, 75 patients who underwent pelvic exenteration for gynecologic cancer were retrospectively reviewed. Sixty-two patients had recurrent disease and 13 had primary tumors. Forty patients underwent vaginal reconstruction, 21 with TRAM flaps and seven with DIEP flaps. Flap survival, donor-site morbidity, neovagina stenosis, flap harvest time, and hospital stay were registered for both groups. All DIEP flaps survived in all patients. In the TRAM group, however, three flaps were lost because of total necrosis and five presented partial necrosis. Mean harvest time was 63 minutes for the DIEP flap and 105 minutes for the TRAM flap. No abdominal wall complications occurred in the DIEP flap group, whereas four cases of donor-site morbidity were registered in the TRAM group, even though mesh was used in all cases. During follow-up examination, all patients had normal-appearing external genitalia. The DIEP flap seems to be a promising flap for this kind of reconstruction and could replace the TRAM flap. The authors detected a decrease in donor-site abdominal morbidity when using the DIEP flap compared with the TRAM flap. Therapeutic, IV.

A Comparison of the Effects of Epidural and Spinal Anesthesia With Ischemia-Reperfusion Injury on the Rat Transverse Rectus Abdominis Musculocutaneous Flap

The purpose of this study is to compare the effects of spinal and epidural anesthesia on a rat transverse rectus abdominus myocutaneous flap ischemia-reperfusion injury model.Forty Sprague-Dawley rats were divided into 4 experimental groups: group I (n = 10), sham group; group II (n = 10), control group; group III (n = 10), epidural group; and group IV (n = 10), spinal group. After the elevation of the transverse rectus abdominus myocutaneous flaps, all groups except for the sham group were subjected to normothermic no-flow ischemia for 4 hours, followed by a reperfusion period of 2 hours. At the end of the reperfusion period, biochemical and histopathological evaluations were performed on tissue samples.Although there was no significant difference concerning the malonyldialdehyde, nitric oxide, and paraoxonase levels in the spinal and epidural groups, the total antioxidant state levels were significantly increased, and the total oxidative stress levels were significantly decreased in the epidural group in comparison to the spinal group. The pathological evaluation showed that findings related to inflammation, nuclear change rates and hyalinization were significantly higher in the spinal group compared with the epidural group.Epidural anesthesia can be considered as a more suitable method that enables a decrease in ischemia-reperfusion injuries in the muscle flaps.

Complications of breast reconstruction with pedicled TRAM and LDF: a Meta analysis

Objective To analyze the complications of breast reconstruction with pedicled transverse rectus abdominis myocutaneous flap (TRAM flap) and latissimus dorsi flap (LDF).Methods From databases such as CNKI,SinoMed,PubMed,VIP and Cochrane Library and manual search of articles on breast reconstruction with pedicled TRAM and LDF from 1992 to 2002 for the language of both Chinese and English,1493 cases were collected.47 cases were selected after they all were inspected by the excluded and included standards.RevMan 5.0 software was used to perform the Mantele-Haenszel fixed effect model.Results Ten studies reporting outcomes of pedicled TRAM and LDF were used to estimate relative risk (RR) and 95 ％ confidence interval (CI) for complications.There was a 1.7 times increase in the risk of partial flap necrosis (relative risk,1.72; 95 ％ CI,1.02to 2.88) in pedicled TRAM flap patients compared with LDF patients.There was no difference in the risk for fat necrosis (relative risk,1.01; 95 ％ CI,0.60 to 1.72) and total flap loss (relative risk,2.13; 95 ％ CI,0.82 to 5.54) between pedicled TRAM flap and LDF patients (P＞0.05).Conclusions Compared with the pedicled TRAM flap,partial flap loss risk of breast reconstruction with LDF is lower,and the risk of fat necrosis and total flap loss have no statistical difference (P＞0.05). Key words: Pedicled TRAM flap; Latissimus dorsi flap (LDF); Mammaplasty; Complication; Meta analysis

Paradoxical effects of heme arginate on survival of myocutaneous flaps

Ischemia reperfusion injury (IRI) contributes to partial flap and solid organ transplant failure. Heme-oxygenase 1 (HO-1) is an inducible, cytoprotective enzyme which protects against IRI in solid organ transplant models. Heme arginate (HA), a HO-1 inducer, is a promising, translatable, preconditioning agent. This study investigated the effects of preconditioning with HA on the clinical outcome of a myocutaneous IRI model. Forty male Lewis rats were randomized to intravenously receive 1) Control-NaCl, 2) HA, 3) HA and tin mesoporphyrin (SnMP), a HO-1 inhibitor; and 4) SnMP alone. Twenty-four hours later, an in situ transverse rectus abdominis myocutaneous flap was performed under isoflurane anesthesia. Viability of flaps was measured clinically and by laser-Doppler perfusion scanning. In vitro work on human epidermal keratinocytes (HEKa) assessed the effects of HA, SnMP, and the iron chelator desferrioxamine on 1) cytotoxicity, 2) intracellular reactive oxygen species (ROS) concentration, and 3) ROS-mediated DNA damage. In contrast to our hypothesis, HA preconditioning produced over 30% more flap necrosis at 48 h compared with controls (P = 0.02). HA-containing treatments produced significantly worse flap perfusion at all postoperative time points. In vitro work showed that HA is cytotoxic to keratinocytes. This cytotoxicity was independent of HO-1 and was mediated by the generation of ROS by free heme. In contrast to solid organ data, pharmacological preconditioning with HA significantly worsened clinical outcome, thus indicating that this is not a viable approach in free flap research.

Serratus branch as recipient vessel for microvascular tissue transfer in breast reconstruction.

Sir: Although the internal mammary vessels remain the recipient vessels of choice in free flap breast reconstruction, the thoracodorsal vessels are still chosen for a variety of reasons. The use of the internal mammary artery as a recipient vessel is justified despite concern for future coronary revascularization.1 The thoracodorsal vessels continue to be used because of surgeon preference and cases of suboptimal internal mammary vessels upon dissection. The potential disadvantages of the thoracodorsal artery and vein as recipient vessels include difficultly in achieving medial fullness in the final breast mound and the inability to use the latissimus flap for future breast reconstruction. We present a case in which the serratus branch is used as recipient vessels for microvascular tissue transfer, with the advantage of preserving the thoracodorsal vessels for future flap reconstruction. The patient is a 44-year-old woman with history of left breast cancer status post mastectomy, who presented for delayed autologous free flap reconstruction. After excision of the previous mastectomy scar, the prepectoral pocket was created. It was noted that the previous mastectomy scar went quite lateral, and therefore, the decision was made to dissect the thoracodorsal vessels. During the dissection, the serratus branch of the thoracodorsal vessels was noted to be quite large and suitable for microvascular anastomosis (Fig. 1). We chose to use the serratus branch as recipient vessels to spare the thoracodorsal vessels. This would allow for future use of her latissimus muscle for breast or general reconstruction. Fig. 1. Dissection of the thoracodorsal vessels. The serratus branch of the thoracodorsal vessels was found large and suitable for microvascular anastomosis. Few studies have described the use of the serratus branch as recipient vessels for microvascular transfer. Arnez et al2 describe a case of a patient who underwent a free transverse rectus abdominis myocutaneous flap reconstruction with the serratus anterior branch as a recipient vessel, thus conserving the remainder of the thoracodorsal vessels in case they were needed in a secondary salvage surgery. In a study describing their experience with 50 free TRAM flap reconstructions, Arnez et al3 describe 1 of 2 reconstructions using the serratus branch, citing the superior back flow of the serratus branch in comparison with the flow of the proximal pedicle. Another group describes their use of the serratus branch as recipient vessels in 4 patients undergoing partial breast reconstruction with mini-superficial inferior epigastric artery and mini-deep inferior epigastric artery perforator flaps to achieve the proper anatomic placement of miniflaps.4 Most cases describe the use of the serratus branch and other distal branches of the thoracodorsal artery as a means to successfully salvage a deep inferior epigastric artery perforator flap through retrograde flow anastomosis.5 In conclusion, the serratus branch of the thoracodorsal vessels provides a viable recipient site for microvascular tissue transfer with the advantages of sparing the thoracodorsal vessels for future latissimus flap reconstruction.

Nipple-Sparing Mastectomy in Patients with a History of Reduction Mammaplasty or Mastopexy

INTRODUCTION: Nipple-sparing mastectomy has gained popularity, but the question remains whether it can be offered safely to women with prior history of reduction mammaplasty or mastopexy. Presented is our updated experience with offering nipple-sparing mastectomy to this patient population. METHODS: Patients at our institution who had reduction mammaplasty or mastopexy prior to nipple-sparing mastectomy were identified and their records reviewed. Outcomes measured include nipple-areolar complex viability, mastectomy flap necrosis, infection, cancer in the nipple-areolar complex and breast cancer recurrence. RESULTS: The records of our nipple-sparing mastectomy patients from 2006 through 2012 were reviewed. We present eleven patients (n=19 breasts) who underwent nipple-sparing mastectomy following reduction mammaplasty or mastopexy. Seventeen breasts had reduction mammaplasties while the remaining two had mastopexies. In all cases, reduction mammaplasty or mastopexy were in the patient’s surgical history and not performed as part of a planned two stage nipple-sparing mastectomy procedure. The mean age of the patients was 47.5 and the mean BMI was 27.6. None of the patients in this subset were diabetic, and one patient was a smoker. Twelve breasts had therapeutic resections, and seven were for prophylactic indications. Average time elapsed between reduction mammaplasty or mastopexy and nipple-sparing mastectomy was 104.3 months (range, 33 days to 40 years). Fourteen patients were reconstructed immediately with tissue expanders, one with a latissimus dorsi flap with immediate implant and four with immediate transverse rectus abdominis myocutaneous free flaps. Prior reduction mammaplasty or mastopexy incisions were used in all cases. Complications included one hematoma requiring evacuation, one breast with mastectomy flap necrosis, and one displaced implant requiring revision. There were no positive subareolar biopsies. Nipple viability complications included a partial necrosis rate of 15.8% (3/19). Mean follow-up time was 14.5 months. CONCLUSION: Our updated experience demonstrates that the outcomes of nipple-sparing mastectomy in patients with a history of reduction mammaplasty or mastopexy are comparable to the standards for patients who undergo nipple-sparing mastectomy alone.

Applying Deliberate Practice to Plastic Surgery Residency Training

INTRODUCTION: To assess the impact of K. Anders Ericsson’s theory of deliberate practice1 on resident education by evaluating procedure times of breast reconstruction utilizing transverse rectus abdominis myocutaneous (TRAM) flaps. METHODS: TRAM flap breast reconstruction cases with resident participation at the Moffitt Cancer Center from 2009-2011 were retrospectively reviewed. Residents were trained according to the deliberate practice didactic model over their four-month rotations and trained along a continuum of increasing resident independence.2, 3, 4 Operative times were assessed and categorized into the 1st, 2nd, 3rd, and 4th months of the rotation to determine improvement in operating room efficiency. RESULTS: A total of 75 cases (n=75) met inclusion criteria. The median procedure duration for the 1st, 2nd, 3rd, and 4th months was 5.63 hours, 5.17 hours, 4.93 hours, and 4.80 hours, respectively. While the decline in procedure time during the four-month interval was not statistically significant (p=0.2440), the correlation coefficient for operative times for these cases over the four months was significant (r=0.25, p=0.048) (Table 1, Figure 1).Table 1: Procedure duration of TRAM cases categorized by month of four-month rotation. The median procedure duration decreased during each of the month-long blocks, but the results were not signification (p=0.2440).Figure 1: Duration in OR (hours) versus training months. The black line represents all cases, whereas unilateral cases are in red and bilateral cases are in green. The correlation coefficient was -0.25, which is represented by the slope of the black line. The correlation coefficient was significant (p=0.048).CONCLUSION: This study marks the first application in the surgical literature of the theory of deliberate practice to a complex skill set. The data shows a decrease in operative times over each month interval of the residents’ rotations. Further evaluation is warranted to determine whether this didactic model can be formalized and accelerate the acquisition of the complex skill set required for breast reconstruction.

Effect of Acetylsalicylic Acid on Microvascular Thrombosis in Autologous Breast Reconstruction

Although advances in microsurgery have increased success rates of autologous breast reconstruction, microvascular thrombosis still remains a major concern as a cause of flap failure. At present, no evidence-based guidelines on pharmacological prevention of microvascular thrombosis exist. This study investigates the effect of acetylsalicylic acid on the incidence of microvascular complications in patients undergoing autologous breast reconstruction. Patients undergoing deep inferior epigastric artery perforator or free transverse rectus abdominis myocutaneous flap breast reconstruction at two academic centers in the Netherlands between 2005 and 2011 were included. Patients at one center received once daily 0.6 mL of nadroparine and 40 mg acetylsalicylic acid, while patients at the other center received 0.6 mL nadroparine only. A total of 430 consecutive patients underwent 592 breast reconstructions. No statistically significant differences were found between the two groups in the incidence of flap failure (2.8 and 2.5%), microvascular thromboembolic complications (2.6 and 3.8%), venous congestion (3.4 and 2.8%), or overall complications (28.0 and 32.3%). Hematoma tended to occur more often in the group receiving acetylsalicylic acid (9.2 and 4.7%).It was found that no protective effect of acetylsalicylic acid on microvascular complications was present. Given its known risks and the somewhat increased occurrence of hematoma in the present study, we stopped to routinely administer acetylsalicylic acid after autologous breast reconstruction.

Oncoplastic breast surgery: a regional Australian 2012 fellowship experience

Oncoplastic breast surgery (OBS) is a developing subspecialty, although many countries are struggling with how to incorporate training in OBS as part of the established breast surgery subspecialization pathways. UK and Brazil have surged ahead with established formal training programmes, whereas countries such as Australia still rely on ad hoc training by interested surgeons. Our aim was to review the possibility of including regional training centres with appropriate OBS expertise into a future formal training programme in OBS. An 11-month self-audit was performed by the Fellow based in Port Macquarie, in a Breast Surgeons Society of Australia and New Zealand Incorporated accredited Fellowship. The audit template and reconstructive database, which were utilized in this study were supplied by Breast Surgeons Society of Australia and New Zealand Incorporated. OBS procedures made up 41% of total breast procedures performed, with 46% of these being performed by the Fellow. These oncoplastic procedures included 22 reconstructive breast procedures, with 15 (68%) being performed by the Fellow. These procedures involved mainly pedicle transverse rectus abdominis myocutaneous flap reconstruction after mastectomy and breast implant reconstruction techniques. Minor and major complications accounted for a small percentage of operated cases and are discussed. Current British Association of Surgical Oncology (BASO) guidelines specify recommendations regarding BASO Level I and II OBS training, experience and exposure. Based on the experience during the fellowship presented in this audit, we discuss the merits of using regional Australian hospitals like Port Macquarie Base Hospital to make up the cohort of BASO Level I units to provide the core foundation experience in OBS to the next generation of Australian oncoplastic breast fellows.

Simultaneous Contralateral Reduction Mammoplasty or Mastopexy During Unilateral Free Flap Breast Reconstruction

After unilateral breast reconstruction, a procedure on the contralateral breast is often needed to achieve symmetry. However, there is no consensus regarding when to perform the contralateral balancing procedure. Here, we present a single surgeon's experience with performing contralateral symmetry procedures simultaneously with free flap autologous breast reconstruction. We evaluated 77 consecutive patients (mean age, 50.5 years) who underwent abdominal-based free flap unilateral breast reconstruction and a simultaneous contralateral breast procedure performed by a single surgeon. Thirty-eight patients (49%) underwent immediate breast reconstruction, and 39 patients (51%) underwent delayed reconstruction. Forty patients (52%) received preoperative chemotherapy, and 31 (40%) received preoperative radiation therapy. Patients' mean body mass index was 28.3 kg/m. The most common free flaps were the muscle-sparing transverse rectus abdominis myocutaneous flap (n = 53) and deep inferior epigastric perforator flap (n = 22). Contralateral procedures included reduction mammoplasty (n = 48, 62%) and mastopexy (n = 29, 38%). In 43 patients (56%), breast reconstruction was completed after a single stage, and in 34 patients (44%), revisions were performed (flap: n = 16, 21%; contralateral breast: n = 8, 10%; both breasts: n = 10, 13%). Mean follow-up for patients was 53.2 months. At last follow-up, most patients had no evidence of disease (n = 68, 88%), six patients (8%) had died of disease, 1 patient (1%) was alive with disease, and 2 patients (3%) had died of other causes. For patients who need contralateral reduction mammoplasty or mastopexy for symmetry, performing these procedures and breast reconstruction simultaneously facilitates single-stage breast reconstruction in most patients.

An Assessment of the Risks and Benefits of Immediate Autologous Breast Reconstruction in Patients Undergoing Postmastectomy Radiation Therapy

The utility of immediate autologous breast reconstruction in patients likely to undergo radiation therapy remains controversial. The purpose of this study was to perform a quantitative outcomes assessment of patients undergoing immediate free-flap breast reconstruction and postmastectomy radiation therapy (PMRT). A retrospective chart review was performed of patients undergoing free-flap breast reconstruction by the senior authors (L.C.W. and J.M.S.) between 2005 and 2009. The treatment group included patients who underwent immediate free-flap breast reconstruction and received PMRT. The control group consisted of patients undergoing immediate breast reconstruction without PMRT. Variables assessed included postoperative complications and revision surgery. Four hundred seven women underwent immediate free-flap breast reconstruction for a total of 655 flaps. In the cohort that underwent unilateral reconstruction, there was a higher incidence of volume loss (28.26% vs 4.42%, P < 0.0001) and fat necrosis (19.57% vs 3.54%, P = 0.002) in the PMRT group. In the cohort that underwent bilateral reconstruction, there was a higher rate of volume loss for those in the PMRT group (19.75% vs 1.0%, P < 0.0001). However, for both patients who underwent unilateral reconstruction and those who underwent bilateral reconstruction, the PMRT group underwent similar rates of revision surgery. The cohort that underwent bilateral reconstruction experienced a higher incidence of volume loss in radiated perforator flaps (39%) vs muscle-sparing free transverse rectus abdominis myocutaneous flaps (12%; P = 0.013). Postmastectomy radiation therapy can result in volume loss and fat necrosis, yet there are no increases in other complications or revision procedures. The deleterious effects of PMRT do not preclude the decision for immediate autologous reconstruction.

Complications and morbidity following breast reconstruction – a review of 16,063 cases from the 2005–2010 NSQIP datasets

Post-operative complications pose a significant set-back for patients undergoing breast reconstruction. This study aims to characterize factors associated with postoperative complications following breast reconstruction using the National Surgical Quality Improvement Program (ACS-NSQIP) database from 2005–2010. The 2005-2010 ACS-NSQIP databases were reviewed, identifying encounters for CPT codes including either implant-based reconstruction (immediate, delayed, and tissue expander) or autologous reconstruction (pedicled transverse rectus abdominus myocutaneous (TRAM), free TRAM, and latissimus dorsi flap with or without implant). Complications were characterized into three categories: major surgical complications, wound complications, and medical complications. During the study period 16,063 breast reconstructions were performed. Autologous reconstructions were performed in 20.7% of patients and implant-based in 79.3%. The incidence of major surgical complications was 8.4%, whereas the incidence of medical and wound complications was 1.6% and 3.5%, respectively. Independent risk factors for major surgical complications included: immediate and autologous reconstructions, obesity, smoking, previous percutaneous cardiac surgery (PCS), recent weight loss, bleeding disorder, recent surgery, ASA ≥ 3, intra-operative transfusion, and prolonged operative times. Risk factors for medical complications included: autologous reconstruction, obesity, tumor involving CNS, bleeding disorders, recent surgery, ASA ≥ 3, intra-operative transfusion, and prolonged operative times. This study characterizes the incidence of surgical and medical complications following breast reconstruction using a large, prospective multicentre dataset. Key identifiable risk factors associated with both surgical and medical morbidity included: autologous breast reconstruction, obesity, ASA ≥ 3, bleeding disorders, and prolonged operative time. Data derived from this cohort can be used to risk-stratify patients and to enhance perioperative decision-making.

Impact of Prior Ipsilateral Chest Wall Radiation on Pedicled TRAM Flap Breast Reconstruction

This study compares complication rates between transverse rectus abdominis myocutaneous (TRAM) flaps based on previously irradiated versus nonirradiated superior pedicles to assess the impact of prior ipsilateral chest wall radiation on pedicled TRAM flap breast reconstruction. A retrospective study of 302 consecutive TRAM flap reconstructions was performed; 76 TRAM flaps based on a previously irradiated superior epigastric pedicle were compared to 226 TRAM flaps based on a nonirradiated pedicle in medical comorbidities, oncologic data, and complications. Patients having undergone previous chest wall irradiation had a higher cancer stage, but demographic data were otherwise similar within the groups. Previous chest wall irradiation did not result in increased rate of flap loss, infection, and fat necrosis. However, there was a trend toward higher revision rate in the previously irradiated TRAM group. Previous radiation to the superior epigastric pedicle is not associated with a significant increase in flap complications and should be considered a viable modality for pedicled TRAM flap breast reconstruction.

Surgical Management of Silicone Mastitis: Case Series and Review of the Literature

Free silicone injection for breast augmentation, which became widespread in the 1960s and continues illicitly to this day, has well-known adverse effects. In this retrospective chart review of 14 patients treated for silicone mastitis from 1990 to 2002, we present our experience with the surgical management of patients with silicone mastitis. All the patients were women, ranging in age from 49 to 76years old (mean age=58.8). Patients presented to us a mean of 29.9years after their free silicone breast injection. Treatment modalities were analyzed, and, specifically, methods of breast reconstruction involving autologous tissue transfers, implants, or a combination were evaluated. The majority of patients (12 of 14) required mastectomies for extensive silicone-infiltrated tissues. The remaining two patients had focal areas of disease and were successfully treated with excision and local breast parenchyma flaps. Autologous reconstruction was performed with a total of 20 flaps, including 12 free transverse rectus abdominis myocutaneous flaps, 4 free superior gluteal artery perforator (SGAP) flaps, and 4 pedicled latissimus dorsi (LD) flaps. Two patients had bilateral implant-based breast reconstruction. A variety of reconstructive options are available for patients presenting with silicone mastitis. Once an appropriate breast cancer workup has been performed, the surgical goal is to excise as much of the silicone-infiltrated tissues as possible before reconstruction. To our knowledge, this is the first reported series that incorporates the use of SGAP and LD flaps as a means of autologous tissue reconstruction for silicone-infiltrated breasts. This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .

The differential effect of BMI on prosthetic versus autogenous breast reconstruction: A multivariate analysis of 12,986 patients

BackgroundThe comparative safety of breast reconstruction in obese patients remains to be clearly defined. This study utilized multi-institutional data to characterize the effect of body mass index (BMI) on breast reconstruction outcomes. MethodsUtilizing Current Procedural Terminology (CPT) codes, patients undergoing tissue expander, pedicled transverse rectus abdominis myocutaneous (TRAM) flap, latissimus dorsi flap, and free flap breast reconstruction were identified in the National Surgical Quality Improvement Program (NSQIP) database. Patients were stratified as obese (BMI ≥ 30) and non-obese (BMI < 30). Overall postoperative morbidity, flap complications, non-flap complications, and reoperation rates were compared among the groups. ResultsOf 12,986 patients who underwent breast reconstruction, 3636 (28.0%) were obese. Overall morbidity was significantly elevated in obese patients across all forms of reconstruction (p < 0.05). BMI was correlated with increased surgical complications for tissue expander, pedicled TRAM, and free flap reconstructions (OR = 1.09, OR = 1.05, OR = 1.10, respectively; p < 0.05). Medical complications were higher in obese patients undergoing tissue expander and pedicled TRAM reconstructions (p = 0.001 and p < 0.001), but no significant difference was observed in latissimus and free flap reconstruction patients. Compared with obese tissue expander recipients, obese patients reconstructed using autologous tissue had higher rates of reoperations (12.8% versus 9.1%), overall morbidity (18.0% versus 9.5%), surgical (12.7% versus 8.3%), and medical complications (9.0% versus 2.2%). ConclusionsThe NSQIP database allows for evaluation and comparison of reconstructive outcomes in the obese population. Increased BMI was associated with higher morbidity in autologous reconstruction than tissue expander reconstruction. Among autologous procedures, latissimus flaps experienced the lowest captured 30 day morbidity.

Can intensity-modulated radiation therapy spare the central flapped area while encompassing the target volume in radiotherapy after immediate breast reconstruction?

Radiotherapy increases the morbidity of immediate breast reconstruction. To spare the flapped area without an adverse dose distribution of the target volume and organ at risks, various radiation techniques were assessed. Twelve breasts undergoing skin-sparing mastectomy and immediate transverse rectus abdominis myocutaneous flap reconstruction were evaluated. After a delineation of whole breast, the doughnut-like breast target volume (BTV) including the chest wall and skin and the subtracted central flapped volume (FV) were defined. The opposed wedge tangential radiotherapy (3-dimensional conformal radiotherapy (3-D CRT) ), field-in-field radiotherapy (FiF), inverse intensity-modulated radiotherapy (iIMRT), volumetric modulated arc radiotherapy (VMRT) and the mixture of FiF and iIMRT (HYBRID) were tried. Total 50 Gy was prescribed to the BTV. The paired student t-tests were performed. The V47.5Gy of the BTV was improved in iIMRT and VMRT compared with 3-D CRT and FiF. The mean FV doses in iIMRT and VMRT were 76.7 ± 3.9% and 85.5 ± 4.0%, respectively. However the mean ipsilateral lung doses were aggravated by iIMRT and VMRT. In terms of HYBRID, the V47.5Gy for the BTV was 97.5 ± 0.7%. The mean FV dose was 89.4 ± 2.1%. While the mean FV dose in HYBRID was 13.7 ± 2.1% (P < 0.001) lower than FiF, it was 12.8 ± 1.9% (P < 0.001) higher than iIMRT. The mean ipsilateral lung dose in HYBRID was 2.8 ± 1.9% (P < 0.001) worse than FiF, and 2.6 ± 1.8% (P < 0.001) better than iIMRT. The HYBRID could minimise the adverse dose distribution of lung and reduce 10% of the mean dose to the flapped area. For patients with adverse factors for the failure of breast reconstruction, the HYBRID could be considered.

Unilateral and Bilateral Breast Reconstruction with Pedicled TRAM Flaps: An Outcomes Analysis of 188 Consecutive Patients.

Background:The abdomen remains a popular donor site for autologous tissue breast reconstruction. Recently, however, some authors have questioned whether the pedicled transverse rectus abdominis myocutaneous (TRAM) flap should remain a first-line reconstruction option.Methods:Between 1998 and 2009, 188 women underwent breast reconstruction with pedicled TRAM flaps by the senior author (J.A.A.). All TRAM flaps involved reinforcement of the abdominal wall repair with polypropylene mesh. Reconstruction was unilateral in 164 patients and bilateral in 24 patients, yielding a total of 212 flaps.Results:The mean follow-up period was 36 months. There were no complete flap losses. Overall hernia rate for the series was 1.6%, and overall abdominal bulge rate was 0.5%. When combining all types of morbidity, 38 unilateral (23.2%) and zero bilateral TRAM flap patients experienced flap site complications (P = 0.005), and 16 unilateral (9.8%) and 5 bilateral patients (20.8%) experienced donor site complications (P = 0.155). For morbidity that required a return to the operating room, the overall rate was 4.3% for unilateral TRAM flap patients and 4.2% for bilateral TRAM flap patients. Flap site morbidity was significantly associated with obesity, former or active smoking, and receiving 2 or more adjuvant therapies. Donor site morbidity was significantly associated with obesity.Conclusions:The pedicled TRAM flap continues to be an excellent option for breast reconstruction. Complication rates for both unilateral and bilateral TRAM flaps were low in this series, with no complete flap losses and just 4.3% of patients requiring a return to the operating room secondary to morbidity.